The event is a great opportunity to keep up-to-date and to be inspired by the UK's leading movers and shakers, as well as by patients and practitioners. Thought-provoking, engaging and challenging speakers from across health, social care and industry will question ‘What works?’ and ‘How much does it cost?’ whilst still delivering high quality integrated care.
The core themes for this year’s conference are:
- Innovation: improving services and standards of care
- Access: the future for life sciences and market access
- Transformation: collaborating to join up care
As always the NICE Field Team will be available to answer any burning questions during their Q&A and clinics throughout the conference. This is a great opportunity to discuss any issues with NICE guidance – from challenges around implementation to local obstacles. These sessions always prove to be invaluable.
OPEN Health will be represented at the event by our Market Access and Real World Evidence companies within the group – OPEN Access Consulting and pH Associates. OPEN Access Consulting and pH Associates collaborate to offer strategic market access and RWE consultancy. The highly qualified 50+ strong team provide integrated market access support through expert strategic consultancy and the design and implementation of robust real world evidence programmes.
pH Associates is a specialist Real World Evidence (RWE) consultancy demonstrating value and outcomes to drive access to medicines through robust RWE. pH specialise in identifying RWE needs and developing robust RWE projects. The core services expertly conducted include the analysis of existing data sets and the generation of RWE via a range of observational study designs to create bespoke data to address our client’s needs. The expanding expert Patient Centred Outcomes Team focusses on measuring the outcomes that really matter to patients.
OPEN Access Consulting is a full service Market Access agency with expertise in the delivery of global, EU and UK market access programmes. OPEN Access services include pricing and reimbursement landscape assessment, evidence evaluation, payer research and engagement and HTA strategy development and implementation. Our project expertise extends across the pharmaceutical mix of new chemical entities, generics and devices. Payer engagement is central to our service offerings to ensure optimal reimbursement and patient access to innovative technologies.
To keep up with the latest news from NICE 2017 you can visit the NICE Twitter feed.
For more information on what OPEN Health, and specifically pH Associates and OPEN Access Consulting can offer, please visit stand 4 at NICE 2017.
Alternatively, you can get in touch via: Sam Oliver, Joint MD, pH Associates at SamOliver@phassociates.com or Dorinda Hickey, CEO, OPEN Access Consulting at DorindaHickey@openaccessconsulting.com.